2-benzenesulfonylamino-1-(4-benzyloxyphenyl) ethanone | 114963-03-0

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 2-benzenesulfonylamino-1-(4-benzyloxyphenyl) ethanone
• 英文别名: 2-Benzenesulfonylamino-1-(4-benzyloxyphenyl)ethanone；N-[2-oxo-2-(4-phenylmethoxyphenyl)ethyl]benzenesulfonamide
• CAS: 114963-03-0
• 化学式: C₂₁H₁₉NO₄S
• 分子量: 381.452
• InChiKey: CEFULRUFLNIOMV-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.8
• 重原子数：
  27
• 可旋转键数：
  8
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.1
• 拓扑面积：
  80.8
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  碘苯 、 2-benzenesulfonylamino-1-(4-benzyloxyphenyl) ethanone 生成 2-benzenesulfonylamino-1-(4-benzyloxyphenyl)-1-phenylethanol
  参考文献：
  名称：

  IVAKUMA, TAKEHO;KAVAGUTI, TAKAYUKI;YAMASITA, TOEXARU

  摘要：

  DOI：
• 作为产物：
  描述：

  2-氨基-1-(4-苯基甲氧基苯基)乙酮 、 苯磺酰氯 、 potassium carbonate 、 四氢呋喃 、 水 以89%的产率得到
  参考文献：
  名称：

  IWAKUMA, TAKEO;KAWAGUCHI, TAKAYUKI;YAMASHITA, TOYOHARU;SASAKI, YOSUHIKO;S+

  摘要：

  DOI：

文献信息

• Phenoxyacetic acid derivatives, pharmaceutical compositions and methods
  申请人：Tanabe Seiyaku Co., Ltd.

  公开号：US04948810A1

  公开（公告）日：1990-08-14

  Novel phenoxyacetic acid derivative of the formula: ##STR1## wherein R is a substituted or unsubstituted phenyl group, naphthyl group or a sulfur-containing 5-membered hetero-monocyclic group, R.sup.1, R.sup.2, R.sup.3 and R.sup.4 are hydrogen atom, a lower alkyl group, a phenyl-lower alkyl group or phenyl group, R.sup.5 is hydrogen atom or a lower alkyl group, R.sup.6 is carboxyl group, a protected carboxyl group, hydroxy group or a di(lower alkyl)-amino group, Ring A is a substituted or unsubstituted phenylene group, m is 0 or 1 and n is an integer 0 to 5, provided that, when m is 0, (1) at least either one of R.sup.1 to R.sup.4 is or/are a phenyl-lower alkyl group or phenyl group, (2) at least either one of R.sup.1 to R.sup.4 is or/are a lower alkyl group, and R.sup.6 is hydroxy group, or (3) all of R.sup.1 to R.sup.4 are hydrogen atom, and Ring A is a substituted phenylene group, or a pharmaceutically acceptable salt thereof are disclosed. Said derivative (I) and a pharmaceutically acceptable salt thereof have a potent platelet aggregation-inhibiting activity.

  式(I)所示的新型苯氧乙酸衍生物：##STR1##其中R为取代或未取代的苯基、萘基或含硫的5元杂单环基团，R1、R2、R3和R4为氢原子、低级烷基、苯基低级烷基或苯基，R5为氢原子或低级烷基，R6为羧基、保护的羧基、羟基或二(低级烷基)氨基，环A为取代或未取代的亚苯基，m为0或1，n为0至5的整数，条件是，当m为0时，(1)R1至R4中至少有一个为或为苯基低级烷基或苯基，(2)R1至R4中至少有一个为或为低级烷基，且R6为羟基，或(3)R1至R4全部为氢原子，且环A为取代的亚苯基，或其药学上可接受的盐。所述衍生物(I)及其药学上可接受的盐具有强效的血小板聚集抑制活性。
• Phenoxyacetic acid derivatives and preparation thereof
  申请人：Tanabe Seiyaku Co., Ltd.

  公开号：US04866196A1

  公开（公告）日：1989-09-12

  Novel phenoxyacetic acid of the formula: ##STR1## wherein Ring A is phenylene group or a phenylene group having 1 to 2 substituent(s) selected from a lower alkyl group, a lower alkoxy group and a halogen atom; either one or two group(s) of R.sup.1, R.sup.2, R.sup.3 and R.sup.4 are a lower alkyl group, and the other groups are hydrogen atom; R.sup.5 is phenyl group or a phenyl group having 1 to 3 substituent(s) selected from a lower alkyl group, a halogen atom a lower alkoxy group and nitro group; and --COOR.sup.6 is carboxyl group or a protected carboxyl group, or a salt thereof are disclosed. Said derivative (I) and a salt thereof have a potent platelet aggregration-inhibiting activity.

  该式中的新型苯氧乙酸：其中环A是苯基或具有1至2个取代基（选择自较低的烷基、较低的烷氧基和卤原子）的苯基；R.sup.1、R.sup.2、R.sup.3和R.sup.4中的一个或两个基团是较低的烷基，其余基团为氢原子；R.sup.5是苯基或具有1至3个取代基（选择自较低的烷基、卤原子、较低的烷氧基和硝基）的苯基；--COOR.sup.6是羧基或受保护的羧基，或其盐。所述衍生物（I）及其盐具有强大的抑制血小板聚集活性。
• Phenoxyacetic acid derivatives, preparation thereof, pharmaceutical compositions comprising them and use
  申请人：TANABE SEIYAKU CO., LTD.

  公开号：EP0325245A1

  公开（公告）日：1989-07-26

  Novel phenoxyacetic acid derivative of the formula: wherein R is a substituted or unsubstituted phenyl group, naphthyl group or a sulfur-containing 5-membered hetero-monocyclic group, R¹, R², R³ and R⁴ are hydrogen atom, a lower alkyl group, a phenyl-­lower alkyl group or phenyl group, R⁵ is hydrogen atom or a lower alkyl group, R⁶ is carboxyl group, a protected carboxyl group, hydroxy group or a di(lower alkyl)-amino group, Ring A is a substituted or unsubstituted phenylene group, m is 0 or 1 and n is an integer of 0 to 5, provided that, when m is 0, (1) at least either one of R¹ to R⁴ is or/are a phenyl-lower alkyl group or phenyl group, (2) at least either one of R¹to R⁴ is or/are a lower alkyl group, and R⁶ is hydroxy group, or (3) all of R¹ to R⁴ are hydrogen atom, and Ring A is a substituted phenylene group, or a pharmaceutically acceptable salt thereof are disclosed. Said derivative (I) and a pharmaceutically aceptable salt thereof have a potent platelet aggregation-inhibiting activity. The derivative (I) is used for the prophylaxis or treatment of thrombotic diseases in warm-blooded animals. The invention includes a variety of prepara­tion methods for the above derivative (I) and pharma­ceutical compositions comprising said derivative (I) in therapeutically effective amounts.

  式中的新型苯氧乙酸衍生物： 其中 R 是取代或未取代的苯基、萘基或含硫五元杂单环基团，R¹、R²、R³ 和 R⁴ 是氢原子、低级烷基、苯基-低级烷基或苯基、R⁵ 是氢原子或低级烷基，R⁶ 是羧基、受保护的羧基、羟基或二(低级烷基)氨基，环 A 是取代或未取代的亚苯基，m 是 0 或 1，n 是 0 至 5 的整数、 条件是，当 m 为 0 时 (1) R¹ 至 R⁴ 中至少有一个是或/是苯基低级烷基或苯基、 (2) R¹ 至 R⁴ 中至少有一个是或/是低级烷基，且 R⁶ 是羟基，或 (3) 所有 R¹ 至 R⁴ 均为氢原子，且环 A 为取代的亚苯基、 或其药学上可接受的盐。所述衍生物（I）及其药学上可接受的盐具有强效的血小板聚集抑制活性。衍生物（I）可用于预防或治疗温血动物的血栓性疾病。本发明包括上述衍生物（I）的各种制备方法和包含治疗有效量的上述衍生物（I）的药物组合物。
• Phenoxyacetic acid compounds, their preparation, pharmaceutical composition and use
  申请人：TANABE SEIYAKU CO., LTD.

  公开号：EP0255728B1

  公开（公告）日：1991-11-27
• IWAKUMA, TAKEO;KAWAGUCHI, TAKAYUKI;YAMASHITA, TOYOHARU;SASAKI, YOSUHIKO;S+
  作者：IWAKUMA, TAKEO、KAWAGUCHI, TAKAYUKI、YAMASHITA, TOYOHARU、SASAKI, YOSUHIKO、S+

  DOI：——

  日期：——